Skip to main content

Peer Review reports

From: Primary fallopian tube cancer followed by primary breast cancer in RAD51C mutation carrier treated with niraparib as first line maintenance therapy: a case report

Original Submission
24 Nov 2023 Submitted Original manuscript
18 Jan 2024 Reviewed Reviewer Report
28 Jan 2024 Author responded Author comments - HONGWEN YAO
Resubmission - Version 2
28 Jan 2024 Submitted Manuscript version 2
Publishing
30 Jan 2024 Editorially accepted
15 Feb 2024 Article published 10.1186/s13053-024-00274-8

You can find further information about peer review here.

Back to article page